1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports consortia conducting collaborative, multi-site, patient-centric, translational, and clinical research on rare diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities and other research institutions. Confirm the full requirements in the official notice before applying.
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Rare Belonging® Grant Program is sponsored by Alexion Charitable Foundation. The Alexion Charitable Foundation's Rare Belonging® grant program supports programs and services that benefit individuals, caregivers, and families impacted by rare diseases, aligning with its mission to address health disparities within and among the rare disease community. Priorities include science-driven solutions, technology and innovation, patient supports, and research & policy focused on diagnostic pathways and systems improvements. The program specifically seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, especially for those living with or affected by a rare disease.
Alexion Charitable Foundation Grants is sponsored by Alexion Charitable Foundation. The Alexion Charitable Foundation (ACF) invests in projects to ensure that underserved communities have equitable pathways to the care, services, and resources they need to live healthier lives, with a focus on addressing health disparities within the rare disease community.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article